Should Orajel Be Applied To Kids' Teeth?

A child crying through tooth pain at 10 p.m. is one of the most stressful moments a parent faces. The medicine cabinet holds a familiar tube – Orajel. The question that follows is reasonable and urgent: will this help, or will it cause harm? For dental professionals, the same question arises in clinical settings, whether counseling parents during routine visits or responding to calls about at-home pain management.

Orajel is one of the most widely recognized over-the-counter oral pain relief products in the United States. Products marketed as kids' Orajel are available at virtually every pharmacy, and parents frequently reach for them without a full picture of the safety landscape. That landscape has shifted considerably since the U.S. Food and Drug Administration issued a critical safety communication in 2018, warning against the use of benzocaine-containing products in children under 2 years old and urging careful use in older children.

This article covers what Orajel is, what the FDA warning means in practical terms, and how to think through its use – or non-use – for children across different age groups, from Orajel for toddlers through Orajel for a 10-year-old. Dental professionals will find clinical framing alongside the broader patient education context. Parents will find clear, evidence-based answers they can act on tonight.

What Is Orajel And How Does It Work?

Orajel is a brand name for a range of topical oral products, some medicated and some drug-free. The medicated formulations that concern pediatric health professionals contain benzocaine, a local anesthetic that blocks sodium channels in peripheral nerve endings, producing temporary numbness of the treated tissue. Onset is rapid, typically within one to three minutes, and the numbing effect lasts roughly 15 to 20 minutes before saliva dilutes and clears the product.

Benzocaine concentrations in OTC oral products range from 7.5% to 20%, and the brand includes formulations marketed as a kids' toothache gel, general mouth sore products, and adult-strength gels. Importantly, not all Orajel products contain benzocaine. Following the FDA's ongoing warnings, the manufacturer reformulated its Baby line to remove benzocaine entirely, replacing it with drug-free cooling agents such as chamomile extracts.

What Orajel does not do is equally important: it does not treat the underlying cause of pain, whether that is tooth decay, an abscess, a viral mouth sore, or orthodontic pressure. It is a temporary symptomatic measure, not a therapeutic one. For parents and professionals alike, this distinction matters because the presence of temporary pain relief can create a false sense that the underlying problem has resolved when it has not.

For a broader look at age-appropriate dental products, the Dental Reviewed blog covers pediatric oral hygiene tools from toothbrushes to fluoride treatments.

The FDA Warning Every Parent And Clinician Must Know

The safety picture around benzocaine-based oral products in children is not ambiguous. The FDA has issued multiple warnings – in 2006, 2011, and most comprehensively in 2018 – about the risk of a potentially fatal blood disorder associated with benzocaine use in young children. Understanding this warning is the foundation of any responsible conversation about Orajel use in pediatric patients.

What Is Methemoglobinemia?

Methemoglobinemia is a condition in which the oxygen-carrying capacity of red blood cells is severely reduced. Benzocaine, as a potent inducer of oxidative stress, can convert functional hemoglobin into methemoglobin, a form that cannot effectively bind or release oxygen to tissues. At high levels, this oxygen deprivation becomes life-threatening.

Symptoms of methemoglobinemia following benzocaine application include:

• Pale, gray, or blue-tinged skin, lips, or fingernails (cyanosis)

• Rapid or irregular heartbeat

• Shortness of breath or labored breathing

• Unusual fatigue, limpness, or weakness – particularly notable in toddlers

• Headache, dizziness, or confusion in older children who can verbalize

• In severe cases, seizures, coma, or death

Emergency action

If any of these symptoms appear after Orajel use in a child, treat this as a medical emergency. Call 911 or proceed to the nearest emergency room immediately. Do not wait to see if symptoms improve. For guidance, you may also contact Poison Control at 1-800-222-1222.

What The Data Shows

The FDA's 2018 Drug Safety Communication cited more than 400 documented cases of benzocaine-associated methemoglobinemia since 1971. A focused review of 119 cases reported between February 2009 and October 2017 found that the majority were serious and required treatment. Of those 119 cases, 22 occurred in patients under age 18, and 11 were in children younger than 2. A published study in the Western Journal of Emergency Medicine documented a case of a six-year-old who presented with a methemoglobin concentration of 69.9% after benzocaine gel was used for a toothache – a case that required IV methylene blue and oxygen therapy.

Critically, the FDA has confirmed that even low-concentration benzocaine formulations – including products at 7.5% – have triggered methemoglobinemia. There is no benzocaine concentration that can be considered categorically safe in very young children.

The American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) both support the FDA position: benzocaine oral products should not be used in infants under 2 years old, and when used in older children, strict label adherence is required.

Orajel By Age: A Complete Clinical Guide

The appropriateness of Orajel use changes substantially as a child gets older. The following age-by-age guidance reflects current FDA labeling, AAP recommendations, and clinical best practice. This section is intended to give both parents and dental professionals a clear, actionable framework.

Under 2 Years: Do Not Use Benzocaine-Based Products

The FDA's position on this age group is unambiguous: benzocaine-containing oral products should not be used in infants and children under 2. The FDA explicitly classifies this as a contraindication, the strongest warning level available. Topical oral viscous lidocaine is equally contraindicated – the FDA required a black box warning on lidocaine in 2014 following reports of seizures, cardiac events, and six documented deaths in children who received it for teething pain.

For this age group, the appropriate alternatives are:

• Chilled, firm rubber teething rings – refrigerated, not frozen

• Clean-finger gum massage to apply counter-pressure to erupting teeth

• Benzocaine-free Orajel Baby products, which use drug-free cooling agents – these carry no methemoglobinemia risk and are pediatrician-recommended when teething discomfort requires product intervention

• Consultation with a pediatrician or pediatric dentist if discomfort is severe

Even a single use of benzocaine at low concentrations has been associated with methemoglobinemia in the under-2 age group. There is no dose threshold that makes it appropriate. Clinicians should counsel parents explicitly on this point and document the counseling.

Orajel For Toddlers Aged 2–3

The 2-to-3-year age bracket is the zone of highest clinical vigilance when it comes to Orajel for toddlers. FDA labeling permits benzocaine use in children 2 and older, but the risk of methemoglobinemia, while lower than in infants, remains elevated compared to school-age children. Toddlers also cannot reliably communicate symptoms such as headache or dizziness, which makes monitoring for adverse effects more difficult.

If a parent chooses to use an Orajel toddler product in this age range, the following applies:

• Use the smallest amount possible – well under a pea-size

• Apply no more than once every 4 to 6 hours

• Monitor the child continuously for at least 20 minutes after application

• Watch for any change in skin color, breathing pattern, or level of alertness

• Prefer benzocaine-free formulas as the first-line option – they carry none of the same risks

• If the toothache is severe enough to prompt repeated Orajel use, that child should be seen by a doctor

If the toothache or gum discomfort driving Orajel toddler use is severe or persistent, a dental evaluation is the appropriate next step. Toothache at this age frequently reflects tooth decay in primary teeth, and a topical anesthetic will not treat the underlying decay. The Journal of the American Dental Association notes that NSAIDs such as ibuprofen and acetaminophen are generally considered more clinically effective systemic alternatives for pediatric dental pain.

Orajel for a 5-year-old

Children in the 4 to 5 year range are beginning to experience their first loose baby teeth, minor gum soreness from erupting molars, and, depending on their dental history, possible cavity-related discomfort. Orajel for a 5-year-old is appropriate for temporary relief of mild toothaches or gum irritation, provided children 's-strength formulations are used, and the product is applied by an adult.

Clinical guidance for this age group:

• Apply a pea-sized amount or less directly to the affected gum or tooth surface – not across a wide area

• Do not exceed four applications per day

• Wipe away excess gel to prevent swallowing

• If a 5-year-old's tooth pain persists for more than 2 to 3 days, a pediatric dental evaluation is required – Kids' Orajel is a bridge measure, not a treatment

At this age, dental pain is more likely to reflect cavity progression than in younger children. The National Institute of Dental and Craniofacial Research reports that approximately 28% of American children ages 2 to 5 have cavities in their primary teeth. Orajel for a 5-year-old can provide comfort while awaiting an appointment, but the underlying cause demands professional attention.

Orajel for a 7-year-old

Ages 6 and 7 are among the most active periods of dental development. Children in this stage are losing primary teeth and erupting permanent first molars and central incisors. The combination of loose teeth, erupting teeth, and the soreness that accompanies both makes this a common age for parents to seek a kids' toothache gel. Orajel for a 7-year-old is safe and appropriate when used as directed, with the following considerations.

Key guidance:

• Children 's-strength formulations only – adult-strength Orajel (20% benzocaine) is not appropriate for children under 12

• Apply up to four times per day for relief of eruption soreness, loose tooth discomfort, or minor gum irritation – see the Dental Reviewed guide on pediatric pain management for additional context

• Children this age can usually report unusual sensations – instruct parents to discontinue use if the child reports that the product worsens their symptoms

• Do not use Orajel to mask severe or persistent dental pain at this age – pain severe enough to require repeated topical anesthetics every day warrants same-week dental review

Dental pain in 7-year-olds is frequently associated with the eruption of first permanent molars, which can cause prolonged and significant gum soreness. Orajel for a 7-year-old is an appropriate short-term measure for this specific indication, with the understanding that the discomfort will resolve as the eruption completes.

Orajel for a 10-year-old

By age 8 to 10, children are well within the range where benzocaine-based Orajel products are generally well tolerated and clinically appropriate when used correctly. The most common applications of Orajel for a 10-year-old include toothache relief before a dental appointment, discomfort from orthodontic appliances, and irritation from erupting second premolars or second molars.

Practical notes for this age group:

• Children's strength formulations remain the standard – adult-strength products should not be used below age 12 without professional guidance

• For orthodontic soreness, apply a small amount to the specific area of soft tissue irritation – bracket wax should also be offered as a longer-lasting alternative

• Persistent toothache in a 10-year-old most commonly reflects cavity involvement in permanent teeth, which requires professional treatment regardless of how well kids' Orajel manages the pain in the short term – read the Dental Reviewed overview of signs of tooth decay in children for what to monitor

Orajel For Kids' Mouth Sores: Canker Sores, Ulcers, And Orthodontic Irritation

Tooth pain is not the only reason parents reach for a topical oral analgesic. Orajel for kids' mouth sores is a frequent use case, particularly for canker sores (aphthous ulcers) and soft tissue irritation from dental appliances. The appropriateness of this application depends on the type of sore and the child's age.

Canker Sores (Aphthous Ulcers)

Canker sores are non-contagious, shallow ulcers that form on the soft tissue inside the mouth – the inner cheeks, tongue, or gum tissue away from the tooth root. They are among the most common oral conditions in children and adolescents. For children over 2, a small application of kids' Orajel gel to the sore can temporarily numb the tissue and allow more comfortable eating and speaking.

If a child has recurring mouth sores, frequent episodes may indicate a sensitivity to sodium lauryl sulfate (SLS) in toothpaste, a nutritional deficiency, or an underlying systemic condition. Recurring or clustered ulcers should prompt a clinical evaluation rather than continued symptomatic management with a topical anesthetic. For more on this, the Dental Reviewed blog post on canker sores in children covers triggers and prevention in detail.

Cold Sores

Cold sores, caused by herpes simplex virus type 1, appear on the exterior of the lip or perioral skin rather than on the inner mucosa. Standard Orajel gel is not formulated for viral lesions and will not address the underlying viral cause. Orajel does make a specific cold sore product with a different formulation – parents should be directed to that product category rather than standard dental gel for this indication.

Orthodontic Irritation

Brackets, wires, and removable appliances frequently cause soft tissue abrasion and irritation, particularly during the first weeks after placement and following adjustments. For children and adolescents experiencing this type of discomfort, a small targeted application of kids orajel to the irritated tissue can provide short-term relief. Orthodontic wax remains the preferred first-line intervention because it physically shields the tissue, but Orajel offers faster numbing relief.

Gum Soreness From Erupting Teeth

Children over 2 experiencing gum swelling and tenderness around erupting molars or permanent teeth can benefit from a small, targeted application of Kids' Orajel for kids' mouth sores or gum discomfort. Apply only to the specific zone of gum tissue surrounding the erupting tooth, using a cotton swab for precision.

How To Apply Orajel Safely for Children

Proper application technique matters both for effectiveness and safety. The following protocol applies to benzocaine-containing kids orajel products used in children aged 2 and older. Clinicians should walk parents through this process during counseling to reduce the risk of over-application – a key factor in reported adverse events.

• Wash your hands thoroughly with soap and water before and after application

• Use a clean cotton swab or a clean fingertip, not the whole hand, to limit the amount applied

• Squeeze a pea-sized amount of gel onto the swab, less for toddlers

• Apply the gel directly to the specific area of pain – do not spread across the entire gum line

• Gently blot away excess gel with a clean tissue to reduce swallowing risk

• Do not allow the child to eat or drink for 15 to 20 minutes after application to let the product act and then naturally clear

• Do not exceed the package-directed frequency – up to four times per day for children 2 and older

• Store the product out of children's reach – accidental ingestion of a significant amount of benzocaine gel is a medical emergency requiring an immediate call to Poison Control or emergency services

Additional cautions for clinical documentation: Professionals should advise parents to note the time and amount of each application. Children with pre-existing anemia, cardiac conditions, or respiratory conditions such as asthma are at elevated risk for benzocaine-induced methemoglobinemia and require heightened monitoring.

When Orajel Is The Wrong Tool For The Job

The clinical concern with Orajel – and with kids Orajel specifically – is not simply about safety risks from benzocaine. There is also a meaningful risk of parents substituting a topical anesthetic for dental care, using the temporary absence of pain as a proxy for resolution of the underlying problem. Dental professionals see the consequences of this pattern regularly.

Orajel should not be used in the following scenarios:

• As a substitute for a dental evaluation when pain has persisted for more than 3 days

• When there is visible facial swelling, swollen lymph nodes, or fever alongside dental pain, these are signs of an abscess or spreading infection that require antibiotics and professional treatment

• As a long-term daily treatment, tolerance does not develop rapidly, but habitual use can delay the care that is actually needed

• To manage severe throbbing pain that wakes a child at night – this level of pain typically indicates pulp involvement, and the appropriate intervention is a pediatric dental appointment, not topical numbing

Clinical Reminder

A child whose pain resolves completely after Orajel does not necessarily have a minor problem. Benzocaine is an effective local anesthetic. Effective pain control masks the clinical signal, not the cause. Parents should be counseled that the resolution of pain with a kid's toothache gel still requires follow-up evaluation if the pain is significant.

Safer Alternatives To Kids' Toothache Gel

For children of all ages, and for parents who prefer to minimize medication exposure, a range of evidence-supported alternatives to kids' toothache gel can provide meaningful relief. These range from non-pharmacological interventions recommended by the American Academy of Pediatrics to systemic OTC medications that offer more sustained pain control than topical benzocaine.

Non-Pharmacological Options

• Chilled rubber teething rings (refrigerated, not frozen) – effective for toddlers with eruption discomfort

• Cold compress applied to the outside of the cheek – reduces local inflammation and provides counter-stimulation pain relief for a toothache

• Warm salt water rinse (half a teaspoon of salt per cup of warm water) – reduces gingival inflammation and bacteria load; appropriate for children who can rinse and spit, generally from around age 6

• Clean-fingertip gum massage – applies direct counter-pressure to erupting tissue and provides sensory relief, particularly in toddlers

• Gentle flossing around the affected tooth to clear debris – trapped food is a frequently overlooked source of acute gum pain that kids' Orajel cannot address

Pharmacological Alternatives

• Children's ibuprofen (6 months+): age-appropriate ibuprofen provides systemic anti-inflammatory and analgesic relief, which is more sustained and often more effective than topical benzocaine for dental pain. The JADA clinical practice guideline supports NSAIDs as a first-line approach for acute pediatric dental pain

• Children's acetaminophen: an appropriate alternative when ibuprofen is contraindicated – follow weight-based dosing instructions precisely

• Benzocaine-free Orajel Baby products: for children under 2 or parents who prefer drug-free options, these products provide a cooling sensation through natural ingredients with no methemoglobinemia risk. See the Dental Reviewed reviews section for assessed pediatric oral care products

• A note on clove oil: Although clove oil (eugenol) is occasionally referenced in popular guidance as a natural toothache remedy, dental professionals generally do not recommend it for children. At undiluted concentrations, it can cause mucosal irritation and chemical burns, and its safety profile in young children has not been established.

What Dental Professionals Should Know

For clinicians counseling parents about home pain management, the following framework covers the most common clinical scenarios involving Orajel use in pediatric patients.

Pre-Appointment Use

Parents frequently use Orajel for a 5-year-old or Orajel for a 7-year-old to manage discomfort before a scheduled dental visit. This is clinically acceptable provided it does not mask symptoms to the point that the dental examination is compromised. Clinicians should ask at intake whether a topical anesthetic was used, how recently, and at what dose, to guide examination and treatment decisions.

Post-Procedure Guidance

Following a dental extraction or procedure in a child, parents often ask whether they can use Orajel at home. For children over 2, a small application of kids' Orajel to the surrounding gum tissue can supplement ibuprofen-based post-operative pain management. Clinicians should specify children's strength formulations, give explicit dosage instructions, and advise against application directly to the extraction socket.

Counseling On The Masking Problem

One of the most clinically significant concerns with Orajel in children, particularly in the context of kids' Orajel for toddlers, is that effective pain control can give families a false sense that the dental problem has resolved. Documentation of the counseling conversation about this limitation is good clinical practice, particularly in patients with a history of dental anxiety or care avoidance. For resources on building patient trust and parent education into practice workflows, the Dental Reviewed blog offers relevant guidance for dental teams.

Documenting OTC Medication Use

When reviewing a child's medical and dental history, clinicians should specifically ask about recent use of topical anesthetics. Orajel use – particularly frequent or high-volume Orajel toddler use – is relevant to risk stratification for benzocaine sensitivity and should be noted in the patient record.

Recognizing An Adverse Reaction After Orajel Use

Parents and caregivers should be explicitly briefed on the warning signs of methemoglobinemia following the use of any benzocaine-containing product, including Kids' Orajel. The following symptoms may appear within minutes to two hours after application:

• Pale, gray, or blue skin, lips, or fingernails – this is the hallmark sign of reduced oxygen delivery to peripheral tissues

• Rapid, weak, or irregular heartbeat

• Shortness of breath, labored breathing, or unusual respiratory patterns

• Sudden unusual fatigue, limpness, or unresponsiveness in a toddler or young child

• Headache, dizziness, or confusion – older children may be able to report these

• In severe cases, seizures or loss of consciousness

Bottom Line

Orajel can be an appropriate short-term tool for managing oral pain in children, but its safety profile is age-dependent, formulation-dependent, and dose-dependent. The following summary reflects current evidence and regulatory guidance:

For children under 2: Benzocaine-based Orajel is contraindicated. The FDA's position is clear, and the risk of methemoglobinemia is not theoretical – it is documented and occasionally fatal. Use benzocaine-free alternatives.

For Orajel for toddlers aged 2–3, extreme caution is warranted. Benzocaine-free products are the preferred choice. If benzocaine-containing kids orajel is used, apply the smallest possible amount and monitor closely.

For Orajel for a 5-year-old through Orajel for a 10-year-old: children 's-strength benzocaine products are appropriate when used as directed by an adult, with the clear understanding that they provide temporary symptom relief only and should not substitute for professional dental evaluation when pain is persistent or severe.

For Orajel for kids' mouth sores: appropriate for canker sores, orthodontic irritation, and eruption discomfort in children over 2 when applied correctly.

For dental professionals: document counseling, ask about OTC product use at intake, and counsel parents explicitly about the masking risk and the signs of adverse reactions.

This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for diagnosis and treatment recommendations specific to your situation.